As of July 13, 2026, Ligand Pharmaceuticals Incorporated (LGND) has a DilutionWatch DilutionScore of 21/100, rated LOW dilution risk. Ligand Pharmaceuticals Incorporated has a market capitalization of $4.65B, 20.04M shares outstanding, 360 institutional holders tracked. Key dilution vectors include 3.26M outstanding warrants, approximately 999 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
⛅
Watch
Minor dilution signals detected
17%
📜 Warrant Exercise
25%
• Significant warrants: 16% of shares outstanding
🔁 Convertible Conversion
15%
• Convertible debt present: 9.9% potential dilution
💹 Market Data
Market Cap$4.65B
Shares Outstanding20.04M
Float19.57M
Cash$779.40M
Debt$27.50M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 15.2% shares (2026Q1 vs prior)
360 institutional holders · 24.14M shares
#1
BlackRock, Inc.
2.96M shares
#2
JANUS HENDERSON GROUP PLC
2.02M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
1.70M shares
📉 Short Interest
Short Interest2.12M
Days to Cover2.6
% of Float10.8%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2023
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Mar 31, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for LGND Shareholders
Ligand Pharmaceuticals Incorporated (LGND) has a DilutionScore of 21/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.
DilutionWatch tracks 3.3M outstanding warrants for LGND. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.
DilutionWatch tracks over 25 SEC filing types for LGND in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for LGND alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track LGND Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LGND — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for LGND
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.